Everolimus, CAS [[159351-69-6]]

Produktübersicht

• Artikelname: Everolimus, CAS [[159351-69-6]]
• Artikelnummer: MCE-HY-10218
• Hersteller Artikelnummer: HY-10218
• Alternativnummer: MCE-HY-10218-500MG,MCE-HY-10218-100MG,MCE-HY-10218-1G,MCE-HY-10218-50MG,MCE-HY-10218-5MG,MCE-HY-10218-25MG,MCE-HY-10218-200MG,MCE-HY-10218-10MMX1ML,MCE-HY-10218-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: RAD001, SDZ-RAD

Produktbeschreibung

Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2].

Produkteigenschaften

• Molekulargewicht: 958.22
• Reinheit: 99.85
• CAS Nummer: [159351-69-6]
• Formel: C53H83NO14
• Target-Kategorie: Apoptosis,Autophagy,Bacterial,FKBP,mTOR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound